Exact Mass: 423.1713

Exact Mass Matches: 423.1713

Found 133 metabolites which its exact mass value is equals to given mass value 423.1713, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Neolinustatin

2-methyl-2-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butanenitrile

C17H29NO11 (423.1741)


Isolated from flaxseed meal. Neolinustatin is found in many foods, some of which are yardlong bean, european cranberry, hyssop, and macadamia nut. Neolinustatin is found in cereals and cereal products. Neolinustatin is isolated from flaxseed meal.

   

N-Methyl-2,3,7,8-tetramethoxy-5,6-dihydrobenzophenathridine-6-ethanoic acid

N-Methyl-2,3,7,8-tetramethoxy-5,6-dihydrobenzophenathridine-6-ethanoic acid

C24H25NO6 (423.1682)


   

Carbidopa; Levodopa

(2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid - 3-hydroxy-L-tyrosine (1:1)

C19H25N3O8 (423.1642)


   

[4,5-Bis(4-methoxyphenyl)-2-thiazolyl]-(4-methyl-1-piperazinyl)methanone

[4,5-Bis(4-methoxyphenyl)-2-thiazolyl]-(4-methyl-1-piperazinyl)methanone

C23H25N3O3S (423.1617)


D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

13-Aethoxy-1,2,4-trimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin|13-ethoxy-1,2,4-trimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine

13-Aethoxy-1,2,4-trimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin|13-ethoxy-1,2,4-trimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine

C24H25NO6 (423.1682)


   

8-Acetonylcorynoline

8-Acetonylcorynoline

C24H25NO6 (423.1682)


   

(9R*,10S*,13R*)-9-hydroxy-3-methoxy-2-methyl-9-(3,4-dimethoxyphenyl)-14-oxa-biciclo[3.2.1]-octa[f]quinolone|helicterone A

(9R*,10S*,13R*)-9-hydroxy-3-methoxy-2-methyl-9-(3,4-dimethoxyphenyl)-14-oxa-biciclo[3.2.1]-octa[f]quinolone|helicterone A

C24H25NO6 (423.1682)


   

3-benzoyl-5-oxo-1-p-tolyl-pyrrolidine-2,2-dicarboxylic acid diethyl ester

3-benzoyl-5-oxo-1-p-tolyl-pyrrolidine-2,2-dicarboxylic acid diethyl ester

C24H25NO6 (423.1682)


   
   
   
   
   
   
   
   
   
   

Ala Gly Asn Tyr

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C18H25N5O7 (423.1754)


   

Ala Gly Tyr Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanoic acid

C18H25N5O7 (423.1754)


   

Ala Asn Gly Tyr

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]acetamido}-3-(4-hydroxyphenyl)propanoic acid

C18H25N5O7 (423.1754)


   

Ala Asn Tyr Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]acetic acid

C18H25N5O7 (423.1754)


   

Ala Tyr Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}-3-carbamoylpropanoic acid

C18H25N5O7 (423.1754)


   

Ala Tyr Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]acetic acid

C18H25N5O7 (423.1754)


   

Cys Lys Ser Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C15H29N5O7S (423.1788)


   

Cys Ser Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]hexanamido]-3-hydroxypropanoic acid

C15H29N5O7S (423.1788)


   

Cys Ser Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]hexanoic acid

C15H29N5O7S (423.1788)


   

Phe Gly Asn Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C18H25N5O7 (423.1754)


   

Phe Gly Ser Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C18H25N5O7 (423.1754)


   

Phe Asn Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxypropanoic acid

C18H25N5O7 (423.1754)


   

Phe Asn Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]acetic acid

C18H25N5O7 (423.1754)


   

Phe Ser Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxypropanamido]acetamido}-3-carbamoylpropanoic acid

C18H25N5O7 (423.1754)


   

Phe Ser Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]acetic acid

C18H25N5O7 (423.1754)


   

Gly Ala Asn Tyr

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C18H25N5O7 (423.1754)


   

Gly Ala Tyr Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanoic acid

C18H25N5O7 (423.1754)


   

Gly Phe Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C18H25N5O7 (423.1754)


   

Gly Phe Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C18H25N5O7 (423.1754)


   

Gly Gly Gln Tyr

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C18H25N5O7 (423.1754)


   

Gly Gly Tyr Gln

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanoic acid

C18H25N5O7 (423.1754)


   

Gly Asn Ala Tyr

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]propanamido]-3-(4-hydroxyphenyl)propanoic acid

C18H25N5O7 (423.1754)


   

Gly Asn Phe Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-phenylpropanamido]-3-hydroxypropanoic acid

C18H25N5O7 (423.1754)


   

Gly Asn Ser Phe

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-phenylpropanoic acid

C18H25N5O7 (423.1754)


   

Gly Asn Tyr Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]propanoic acid

C18H25N5O7 (423.1754)


   

Gly Gln Gly Tyr

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]acetamido}-3-(4-hydroxyphenyl)propanoic acid

C18H25N5O7 (423.1754)


   

Gly Gln Tyr Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]acetic acid

C18H25N5O7 (423.1754)


   

Gly Ser Phe Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-phenylpropanamido]-3-carbamoylpropanoic acid

C18H25N5O7 (423.1754)


   

Gly Ser Asn Phe

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-phenylpropanoic acid

C18H25N5O7 (423.1754)


   

Gly Tyr Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]propanamido]-3-carbamoylpropanoic acid

C18H25N5O7 (423.1754)


   

Gly Tyr Gly Gln

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]acetamido}-4-carbamoylbutanoic acid

C18H25N5O7 (423.1754)


   

Gly Tyr Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]propanoic acid

C18H25N5O7 (423.1754)


   

Gly Tyr Gln Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanamido]acetic acid

C18H25N5O7 (423.1754)


   
   
   

Lys Cys Ser Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C15H29N5O7S (423.1788)


   

Lys Ser Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C15H29N5O7S (423.1788)


   

Lys Ser Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C15H29N5O7S (423.1788)


   
   
   
   

Asn Ala Gly Tyr

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]acetamido}-3-(4-hydroxyphenyl)propanoic acid

C18H25N5O7 (423.1754)


   

Asn Ala Tyr Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-(4-hydroxyphenyl)propanamido]acetic acid

C18H25N5O7 (423.1754)


   

Asn Phe Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]acetamido}-3-hydroxypropanoic acid

C18H25N5O7 (423.1754)


   

Asn Phe Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]-3-hydroxypropanamido]acetic acid

C18H25N5O7 (423.1754)


   

Asn Gly Ala Tyr

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}propanamido]-3-(4-hydroxyphenyl)propanoic acid

C18H25N5O7 (423.1754)


   

Asn Gly Phe Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-phenylpropanamido]-3-hydroxypropanoic acid

C18H25N5O7 (423.1754)


   

Asn Gly Ser Phe

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxypropanamido]-3-phenylpropanoic acid

C18H25N5O7 (423.1754)


   

Asn Gly Tyr Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-(4-hydroxyphenyl)propanamido]propanoic acid

C18H25N5O7 (423.1754)


   

Asn Ser Phe Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-phenylpropanamido]acetic acid

C18H25N5O7 (423.1754)


   

Asn Ser Gly Phe

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]acetamido}-3-phenylpropanoic acid

C18H25N5O7 (423.1754)


   

Asn Tyr Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]propanamido]acetic acid

C18H25N5O7 (423.1754)


   

Asn Tyr Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}propanoic acid

C18H25N5O7 (423.1754)


   

Gln Gly Gly Tyr

(2S)-2-(2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}acetamido)-3-(4-hydroxyphenyl)propanoic acid

C18H25N5O7 (423.1754)


   

Gln Gly Tyr Gly

2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-(4-hydroxyphenyl)propanamido]acetic acid

C18H25N5O7 (423.1754)


   
   

Gln Tyr Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}acetic acid

C18H25N5O7 (423.1754)


   

Ser Cys Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]hexanamido]-3-hydroxypropanoic acid

C15H29N5O7S (423.1788)


   

Ser Cys Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]hexanoic acid

C15H29N5O7S (423.1788)


   

Ser Phe Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-phenylpropanamido]acetamido}-3-carbamoylpropanoic acid

C18H25N5O7 (423.1754)


   

Ser Phe Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-phenylpropanamido]-3-carbamoylpropanamido]acetic acid

C18H25N5O7 (423.1754)


   

Ser Gly Phe Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-phenylpropanamido]-3-carbamoylpropanoic acid

C18H25N5O7 (423.1754)


   

Ser Gly Asn Phe

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-carbamoylpropanamido]-3-phenylpropanoic acid

C18H25N5O7 (423.1754)


   

Ser Lys Cys Ser

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C15H29N5O7S (423.1788)


   

Ser Lys Ser Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C15H29N5O7S (423.1788)


   

Ser Asn Phe Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]acetic acid

C18H25N5O7 (423.1754)


   

Ser Asn Gly Phe

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]acetamido}-3-phenylpropanoic acid

C18H25N5O7 (423.1754)


   

Ser Ser Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]hexanoic acid

C15H29N5O7S (423.1788)


   

Ser Ser Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]hexanamido]-3-sulfanylpropanoic acid

C15H29N5O7S (423.1788)


   

Tyr Ala Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]acetamido}-3-carbamoylpropanoic acid

C18H25N5O7 (423.1754)


   

Tyr Ala Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]-3-carbamoylpropanamido]acetic acid

C18H25N5O7 (423.1754)


   

Tyr Gly Ala Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}propanamido]-3-carbamoylpropanoic acid

C18H25N5O7 (423.1754)


   

Tyr Gly Gly Gln

(2S)-2-(2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}acetamido)-4-carbamoylbutanoic acid

C18H25N5O7 (423.1754)


   

Tyr Gly Asn Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}-3-carbamoylpropanamido]propanoic acid

C18H25N5O7 (423.1754)


   

Tyr Gly Gln Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}-4-carbamoylbutanamido]acetic acid

C18H25N5O7 (423.1754)


   

Tyr Asn Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]propanamido]acetic acid

C18H25N5O7 (423.1754)


   

Tyr Asn Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]acetamido}propanoic acid

C18H25N5O7 (423.1754)


   

Tyr Gln Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanamido]acetamido}acetic acid

C18H25N5O7 (423.1754)


   

FR122047

1-[[4,5-bis(4-methoxyphenyl)-2-thiazolyl]carbonyl]-4-methyl-piperazine, monohydrochloride

C23H25N3O3S (423.1617)


   

Terazosin hydrochloride

Terazosin hydrochloride

C19H26ClN5O4 (423.1673)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Terazosin hydrochloride is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin hydrochloride works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment[1][2][3].

   

1-[BIS(4-FLUOROPHENYL)METHYL]-4-(4-NITROBENZYL)PIPERAZINE

1-[BIS(4-FLUOROPHENYL)METHYL]-4-(4-NITROBENZYL)PIPERAZINE

C24H23F2N3O2 (423.1758)


   

AVL-292

Spebrutinib

C22H22FN5O3 (423.1707)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

   

3-INDOXYL PHOSPHATE, BIS(2-AMINO-2-METHYL-1,3-PROPANEDIOL) SALT

3-INDOXYL PHOSPHATE, BIS(2-AMINO-2-METHYL-1,3-PROPANEDIOL) SALT

C16H30N3O8P (423.177)


   

o-4-methylcoumarinyl-n-[3-(triethoxysilyl)propyl]carbamate

o-4-methylcoumarinyl-n-[3-(triethoxysilyl)propyl]carbamate

C20H29NO7Si (423.1713)


   

(R)-1-(4-((2-methyloxiran-2-yl)methoxy)phenyl)-4-(4-(trifluoromethoxy)phenoxy)piperidine

(R)-1-(4-((2-methyloxiran-2-yl)methoxy)phenyl)-4-(4-(trifluoromethoxy)phenoxy)piperidine

C22H24F3NO4 (423.1657)


   

1,4-Dioxaspiro[4.5]decane-8-carboxylicacid,8-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-(9CI)

1,4-Dioxaspiro[4.5]decane-8-carboxylicacid,8-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-(9CI)

C24H25NO6 (423.1682)


   

6-{[(3,5-Dioxo-1,2-diphenylpyrazolidin-4-yl)acetyl]amino}hexanoic acid

6-{[(3,5-Dioxo-1,2-diphenylpyrazolidin-4-yl)acetyl]amino}hexanoic acid

C23H25N3O5 (423.1794)


   

L-Asparaginyl-L-glutaminyl-L-tyrosine

L-Asparaginyl-L-glutaminyl-L-tyrosine

C18H25N5O7 (423.1754)


   
   
   

1-[[3-(3,4-Dimethoxyphenyl)-1-phenyl-pyrazol-4-yl]methyleneamino]-3-isopropyl-thiourea

1-[[3-(3,4-Dimethoxyphenyl)-1-phenyl-pyrazol-4-yl]methyleneamino]-3-isopropyl-thiourea

C22H25N5O2S (423.1729)


   

2-[2,2-dimethyl-6-[4-morpholinyl(oxo)methyl]-3-oxo-1,4-benzoxazin-4-yl]-N-phenylacetamide

2-[2,2-dimethyl-6-[4-morpholinyl(oxo)methyl]-3-oxo-1,4-benzoxazin-4-yl]-N-phenylacetamide

C23H25N3O5 (423.1794)


   
   
   
   
   
   
   
   
   
   

(1S,9R,10R,11R)-N-(1,3-benzodioxol-5-ylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1S,9R,10R,11R)-N-(1,3-benzodioxol-5-ylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C23H25N3O5 (423.1794)


   

(1R,9S,10S,11S)-N-(1,3-benzodioxol-5-ylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1R,9S,10S,11S)-N-(1,3-benzodioxol-5-ylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C23H25N3O5 (423.1794)


   
   

[4,5-Bis(4-methoxyphenyl)-2-thiazolyl]-(4-methyl-1-piperazinyl)methanone

[4,5-Bis(4-methoxyphenyl)-2-thiazolyl]-(4-methyl-1-piperazinyl)methanone

C23H25N3O3S (423.1617)


D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   
   
   
   

RG-12525

RG-12525

C25H21N5O2 (423.1695)


RG-12525 is a a specific, competitive and orally effective antagonist of the peptidoleukotrienes, LTC4, LTD4 and LTE4, inhibiting LTC4-, LTD4- and LTE4-inducd guinea pig parenchymal strips contractions, with IC50s of 2.6 nM, 2.5 nM and 7 nM, respectively; RG-12525 is also a peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist with IC50 of appr 60 nM and a potent inhibitor of CYP3A4, with a Ki value of 0.5 μM.

   

STF-31

STF-31

C23H25N3O3S (423.1617)


STF-31 is a selective inhibitor of glucose transporter 1 (GLUT1), with an IC50 of 1 μM. STF-31 is also a NAMPT inhibitor. STF-31 inhibits glucose uptake in renal cell carcinoma (RCC) 4 cells[1][2].

   

20-ethoxy-15,17,18-trimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

20-ethoxy-15,17,18-trimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

C24H25NO6 (423.1682)


   

(20r)-20-ethoxy-15,17,18-trimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

(20r)-20-ethoxy-15,17,18-trimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

C24H25NO6 (423.1682)


   

{2,3,7,8-tetramethoxy-5-methyl-6h-benzo[c]phenanthridin-6-yl}acetic acid

{2,3,7,8-tetramethoxy-5-methyl-6h-benzo[c]phenanthridin-6-yl}acetic acid

C24H25NO6 (423.1682)


   

[(6s)-2,3,7,8-tetramethoxy-5-methyl-6h-benzo[c]phenanthridin-6-yl]acetic acid

[(6s)-2,3,7,8-tetramethoxy-5-methyl-6h-benzo[c]phenanthridin-6-yl]acetic acid

C24H25NO6 (423.1682)


   

3-[(2s,5s,8s)-5,8-dibenzyl-3,6,9-trihydroxy-5,8-dihydro-2h-1,4,7-triazonin-2-yl]propanoic acid

3-[(2s,5s,8s)-5,8-dibenzyl-3,6,9-trihydroxy-5,8-dihydro-2h-1,4,7-triazonin-2-yl]propanoic acid

C23H25N3O5 (423.1794)


   

4-[(2-{2,4-bis[(1-hydroxyethylidene)amino]pteridin-6-yl}ethyl)(methyl)amino]benzoic acid

4-[(2-{2,4-bis[(1-hydroxyethylidene)amino]pteridin-6-yl}ethyl)(methyl)amino]benzoic acid

C20H21N7O4 (423.1655)